Alps Advisors Inc. boosted its stake in shares of Monsanto (NYSE:MON) by 55.9% in the fourth quarter, HoldingsChannel.com reports. The firm owned 7,144 shares of the basic materials company’s stock after purchasing an additional 2,562 shares during the quarter. Alps Advisors Inc.’s holdings in Monsanto were worth $834,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors also recently added to or reduced their stakes in the stock. Scotia Capital Inc. boosted its position in Monsanto by 1.6% during the 2nd quarter. Scotia Capital Inc. now owns 3,765 shares of the basic materials company’s stock valued at $446,000 after purchasing an additional 60 shares during the period. Parkside Financial Bank & Trust boosted its position in Monsanto by 10.2% during the 3rd quarter. Parkside Financial Bank & Trust now owns 4,865 shares of the basic materials company’s stock valued at $583,000 after purchasing an additional 452 shares during the period. Laurel Wealth Advisors Inc. boosted its position in Monsanto by 12.2% during the 3rd quarter. Laurel Wealth Advisors Inc. now owns 4,166 shares of the basic materials company’s stock valued at $499,000 after purchasing an additional 453 shares during the period. Zions Bancorporation boosted its position in Monsanto by 18.2% during the 3rd quarter. Zions Bancorporation now owns 3,184 shares of the basic materials company’s stock valued at $381,000 after purchasing an additional 491 shares during the period. Finally, Yorkville Capital Management LLC raised its stake in Monsanto by 2.7% during the 2nd quarter. Yorkville Capital Management LLC now owns 18,800 shares of the basic materials company’s stock valued at $2,225,000 after acquiring an additional 500 shares in the last quarter. Institutional investors and hedge funds own 75.62% of the company’s stock.
In other news, EVP Steven Mizell sold 8,100 shares of the business’s stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total value of $966,735.00. Following the sale, the executive vice president now owns 56,743 shares of the company’s stock, valued at approximately $6,772,277.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.79% of the stock is currently owned by insiders.
Monsanto (NYSE:MON) last announced its earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share for the quarter, missing the consensus estimate of $0.42 by ($0.01). Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The business had revenue of $2.66 billion for the quarter, compared to the consensus estimate of $2.77 billion. During the same period in the previous year, the firm earned $0.21 EPS. The firm’s revenue was up .3% on a year-over-year basis. equities research analysts expect that Monsanto will post 5.76 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, April 6th will be paid a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.82%. The ex-dividend date is Thursday, April 5th. Monsanto’s dividend payout ratio is presently 39.93%.
Several brokerages have weighed in on MON. Royal Bank of Canada reaffirmed a “hold” rating and set a $128.00 target price on shares of Monsanto in a research note on Wednesday, November 15th. Deutsche Bank reaffirmed a “buy” rating on shares of Monsanto in a research note on Tuesday, January 16th. Wells Fargo & Co reaffirmed a “market perform” rating and set a $128.00 target price (up previously from $118.00) on shares of Monsanto in a research note on Wednesday, January 17th. Finally, Zacks Investment Research downgraded Monsanto from a “buy” rating to a “hold” rating in a research note on Monday, December 11th. Eleven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Monsanto currently has an average rating of “Hold” and a consensus price target of $127.30.
TRADEMARK VIOLATION NOTICE: “Alps Advisors Inc. Has $834,000 Position in Monsanto (MON)” was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The original version of this piece can be accessed at https://www.com-unik.info/2018/02/12/alps-advisors-inc-has-834000-position-in-monsanto-mon.html.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.